CEA is a widely used serum tumor marker and if positive before surgery seemed to be a risk in tumor relapse; moreover, positive CEA is also significantly associated with poorer DFS and OS in LCNEC. The gene discussed is CEACAM5; the disease is large cell neuroendocrine carcinoma.